NEOGENOMICS INC - NOTE 1.250% 5/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q2 2025

Type / Class
Debt / NOTE 1.250% 5/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of NEOGENOMICS INC - NOTE 1.250% 5/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2025 Q2 $0 $0 -$175,101,871 0
2025 Q1 $176,083,000 $175,632,974 -$7,233 99.31% 14
2024 Q4 $175,544,000 $173,154,965 +$181,132 98.26% 14
2024 Q3 $175,394,000 $172,273,794 +$562,030 97.58% 9
2024 Q2 $174,994,000 $170,404,550 -$25,457,036 97.08% 10
2024 Q1 $201,074,000 $195,598,871 -$2,059,081 96.94% 10
2023 Q4 $5,000,000 $4,687,500 93.75% 1
2023 Q3 $200,844,000 $187,440,096 +$462,515 93.07% 11
2023 Q2 $197,364,500 $187,781,679 +$44,005 93.49% 16
2023 Q1 $212,051,000 $197,959,156 +$3,272,227 92.99% 18
2022 Q4 $185,278,150 $169,731,115 +$7,848,030 84.8% 21
2022 Q3 $137,604,500 $124,511,478 +$15,590,745 86.33% 18
2022 Q2 $119,190,500 $106,562,866 -$64,425,547 83.76% 16
2022 Q1 $201,947,000 $181,520,864 -$17,820,751 85.87% 20
2021 Q4 $207,695,000 $246,561,576 +$1,097,446 118.7% 17
2021 Q3 $205,357,000 $303,735,098 +$3,171,286 147.94% 18
2021 Q2 $200,523,000 $285,296,864 -$3,839,925 142.19% 19
2021 Q1 $202,631,000 $304,517,044 -$2,064,053 150.37% 19
2020 Q4 $203,046,000 $329,207,700 -$13,207,579 162.55% 21
2020 Q3 $211,287,000 $263,504,429 +$39,548,080 124.98% 19
2020 Q2 $183,461,170 $197,852,453 +$197,855,920 107.8% 22